Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ginkgo biloba extract improves cognitive performance in Alzheimer's, dementia -- study.

This article was originally published in The Tan Sheet

Executive Summary

GINKGO BILOBA EXTRACT IMPROVES MENTAL PERFORMANCE IN DEMENTIAS for individuals with Alzheimer's disease and multi-infarct dementia, researchers report in a double-blind, placebo-controlled study of 327 patients published in the Oct. 22 Journal of the American Medical Association. Based on the results of the 52-week trial, ginkgo biloba leaf extract (EGb 761) "appears to stabilize and, in an additional 20% of cases (vs. placebo), improve patient's functioning for periods of six months to a year," Pierre Le Bars, MD/PhD, New York Institute for Medical Research, et al., state.

You may also be interested in...



NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

The National Center for Complementary & Alternative Medicine is sponsoring a multicenter study to test the safety, efficacy and tolerability of ginkgo biloba for the prevention of dementia in the elderly, the center announced Sept. 30.

NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

The National Center for Complementary & Alternative Medicine is sponsoring a multicenter study to test the safety, efficacy and tolerability of ginkgo biloba for the prevention of dementia in the elderly, the center announced Sept. 30.

NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

The National Center for Complementary & Alternative Medicine is sponsoring a multicenter study to test the safety, efficacy and tolerability of ginkgo biloba for the prevention of dementia in the elderly, the center announced Sept. 30.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087697

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel